A Review on the Development in the Field of NIDDM based Thiazolidinedione PPARγ Agonists

被引：0

作者：

Banerjee, Pooja S. ^{[1
]}

Samanta, Subir ^{[1
]}

机构：

[1] Birla Inst Technol, Dept Pharmaceut Sci, Ranchi, Bihar, India

来源：

MINI-REVIEWS IN MEDICINAL CHEMISTRY | 2013年 / 13卷 / 05期

关键词：

Natural ligands; Pharmacophore; PPAR gamma; Synthetic ligands; Thiazolidinediones; Type II Diabetes; LIGAND-BINDING; HYPOLIPIDEMIC AGENTS; BIOLOGICAL-ACTIVITY; CRYSTAL-STRUCTURE; RECEPTOR; ALPHA; ROSIGLITAZONE; GLITAZONES; SERIES; LIVER;

D O I：

暂无

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Peroxisome Proliferator Activated Receptors gamma (PPAR) are a class of ligand activated transcription factors with a prominent role in the regulation of metabolic processes. The present work aims towards examining the functional and structural features that facilitate the binding of small molecules based on Thiazolidinedione pharmacophore to PPARs. The intent of this article is to review all the reported thiazolidinediones and associated groups of PPAR gamma ligands.

引用

页码：706 / 712

页数：7

共 50 条

[1] PPAR-γ Thiazolidinedione Agonists and Immunotherapy in the Treatment of Brain Tumors
Lichtor, Terry
Spagnolo, Alessandra
Glick, Roberta P.
Feinstein, Douglas L.
PPAR RESEARCH, 2008, 2008
[2] Design and synthesis of the first generation of dithiolane thiazolidinedione- and phenylacetic acid-based PPARγ agonists
Chittiboyina, Amar G.
Venkatraman, Meenakshi S.
Mizuno, Cassia S.
Desai, Prashant V.
Patny, Akshay
Benson, Stephen C.
Ho, Christopher I.
Kurtz, Theodore W.
Pershadsingh, Harrihar A.
Avery, Mitchell A.
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (14) : 4072 - 4084
[3] Design, synthesis and bioactivity evaluation of thiazolidinedione derivatives as partial agonists targeting PPARγ
Sun, Juan
Liu, Han-Yu
Zhang, Yi-Heng
Fang, Ze-Yu
Lv, Peng-Cheng
BIOORGANIC CHEMISTRY, 2021, 116
[4] Receptor-independent actions of PPAR thiazolidinedione agonists: Is mitochondrial function the key?
Feinstein, DL
Spagnolo, A
Akar, C
Weinberg, G
Murphy, P
Gavrilyuk, V
Dello Russo, C
BIOCHEMICAL PHARMACOLOGY, 2005, 70 (02) : 177 - 188
[5] Pharmacology of PPARα, PPARγ and dual PPARα/γ agonists in clinical development
Duran-Sandoval, D
Thomas, AC
Bailleul, B
Fruchart, JC
Staels, B
M S-MEDECINE SCIENCES, 2003, 19 (8-9): : 819 - 825
[6] Non-thiazolidinedione PPAR γ- and α-dual agonists for the treatment of type II Diabetes mellitus.
Tomiyama, H
Noda, A
Miyamoto, H
Ohkura, Y
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U645 - U645
[7] Design, development and evaluation of novel dual PPARδ/PPARγ agonists
Gathiaka, Symon
Nanayakkara, Gayani
Boncher, Tracey
Acevedo, Orlando
Wyble, Johnathon
Patel, Sagar
Patel, Akash
Shane, Mary Elizabeth
Bonkowski, Blake
Wieczorek, Jason
Rong, Yinghui
Huggins, Kevin
Smith, Forest
Amin, Rajesh H.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (03) : 873 - 879
[8] Novel Benzylidene Thiazolidinedione Derivatives as Partial PPARγ Agonists and their Antidiabetic Effects on Type 2 Diabetes
Sabina Yasmin
Fabio Capone
Antonio Laghezza
Fabrizio Dal Piaz
Fulvio Loiodice
Viswanathan Vijayan
Velmurugan Devadasan
Susanta K. Mondal
Özlem Atlı
Merve Baysal
Ashok K. Pattnaik
Venkatesan Jayaprakash
Antonio Lavecchia
Scientific Reports, 7
[9] Novel Benzylidene Thiazolidinedione Derivatives as Partial PPARγ Agonists and their Antidiabetic Effects on Type 2 Diabetes
Yasmin, Sabina
Capone, Fabio
Laghezza, Antonio
Dal Piaz, Fabrizio
Loiodice, Fulvio
Vijayan, Viswanathan
Devadasan, Velmurugan
Mondal, Susanta K.
Atli, Ozlem
Baysal, Merve
Pattnaik, Ashok K.
Jayaprakash, Venkatesan
Lavecchia, Antonio
SCIENTIFIC REPORTS, 2017, 7
[10] The insulin receptor:: a new anticancer target for peroxisome proliferator-activated receptor-γ (PPARγ) and thiazolidinedione-PPARγ agonists
Costa, V.
Foti, D.
Paonessa, F.
Chietari, E.
Palaia, L.
Brunetti, G.
Gulletta, E.
Fusco, A.
Brunetti, A.
ENDOCRINE-RELATED CANCER, 2008, 15 (01) : 325 - 335

← 1 2 3 4 5 →